Insulin Resistance : Heart Failure
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2007 by University of Dundee.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
University of Dundee
Information provided by:
University of Dundee
ClinicalTrials.gov Identifier:
NCT00486967
First received: June 13, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Whether insulin resistance common among Chronic Heart Failure (CHF) patients in Tayside and identify factors associated with insulin resistance in CHF.
We also want to identify mechanism for the impaired exercise capacity and reduced peak VO2 in CHF
| Condition |
|---|
|
Congestive Heart Failure Heart Failure |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Observational Model: Natural History Time Perspective: Cross-Sectional Time Perspective: Prospective |
| Official Title: | Insulin Resistance: A New Target in Heart Failure |
Resource links provided by NLM:
Further study details as provided by University of Dundee:
Eligibility| Ages Eligible for Study: | 30 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- One hundred patients with Left ventricular Ejection Friction (LVEF) <35% in NYHA class I II III or IV; aged 30-90, attending the CHF clinic will be studied
- Diagnosis of CHF will be based on medical history of exertional dyspneoa, muscle fatigue and/or fluid retention and diminished LVEF (LVEF<35%)
- The diagnosis of ischemic heart disease will be based on documentation of previous myocardial infarction, coronary artery bypass surgery or pathologic findings on coronary angiography. Idiopathic dilated cardiomyopathy will be diagnosed in the absence of a specific etiology for left ventricular dysfunction and on the basis of normal coronary arteries
- All patients should be stable with their treatment and no change in their treatment regimen for > 6 weeks before the study
- Patients with CHF due to coronary artery disease are more likely to have abnormalities in glucose metabolism than are patients with CHF due to idiopathic dilated cardiomyopathy. Therefore, we also plan to study a control group [n=50] of age and sex and BMI matched patients divided into 2 groups 25 with coronary artery disease without heart failure and 25 healthy control. These patients will be identified from the Cardiology Clinics
Exclusion Criteria:
- Patients with decompensated CHF with signs of congestion
- Since the objective of the study is to assess prevalence of insulin resistance in CHF and not CHF secondary to other diseases like diabetes mellitus (DM), patients suffering from DM will be excluded
- Individual found during study cognitively impaired rendering them incapable to take part
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00486967
Contacts
| Contact: Matlooba A ALZadjali, BSc, MD, MPH | 0044(0)1382 660111 ext 33176 | m.alzadjali@dundee.ac.uk |
Locations
| United Kingdom | |
| University of Dundee | Recruiting |
| Dundee, United Kingdom, DD1 9SY | |
| Contact: James Houston 0044(0)1382384664 j.z.houston@dundee.ac.uk | |
| Sub-Investigator: MATLOOBA A ALZadjali, BSC,MD,MPH | |
Sponsors and Collaborators
University of Dundee
Investigators
| Principal Investigator: | Chim C Lang, MD, FRCP | University of Dundee, Scotland, UK |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00486967 History of Changes |
| Other Study ID Numbers: | MAT001 |
| Study First Received: | June 13, 2007 |
| Last Updated: | June 13, 2007 |
| Health Authority: | United Kingdom: Research Ethics Committee |
Keywords provided by University of Dundee:
|
Insulin resistance, heart failure, congestive heart failure, Peak VO2, Endothelial Function, Leptin, TNF. |
Additional relevant MeSH terms:
|
Heart Failure Insulin Resistance Heart Diseases Cardiovascular Diseases Hyperinsulinism Glucose Metabolism Disorders |
Metabolic Diseases Insulin Hypoglycemic Agents Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 23, 2013